Abstract
Aims This study had two primary aims: (1) to assess change in alcohol use and hazardous drinking since the start of the COVID–19 pandemic in the UK; (2) to investigate the extent to which poor inhibitory control and stress were associated with a change in alcohol use and hazardous drinking since the pandemic began.
Methods We interrogated cross-sectional data from the first sweep of the COVID-19 survey, comprising four birth cohorts (13, 453 respondents, aged 19-62 years). Alcohol use, stress, and inhibitory control were self–reported. Change in drinking and hazardous alcohol use were regressed on stress and inhibitory control, adjusting for sex, ethnicity and socioeconomic status.
Results Between fourteen to thirty percent of individuals reported an increase in alcohol use since the start of the pandemic, depending on age and sex. Of these, a substantial proportion (approximately four to ten percent) reported drinking hazardously, thus were at high risk of alcohol–related harm. The effects of stress and inhibitory control were age dependent. In thirty–year–olds, those reporting feeling stressed since the start of the pandemic were around four times more likely to engage in hazardous drinking (OR = 3.92, 95% CI = 1.17–13.15). Among nineteen–year–olds, a one unit increase in impatience was associated with a fourteen percent (ORadjusted = 1.14, 95% CI = 1.05–1.23) increase in the likelihood of drinking more during the lockdown, and a twenty–one percent (ORadjusted= 1.21, 95% CI = 1.05–1.41) increase in the likelihood of drinking hazardously. For those aged thirty or fifty, a one-unit increase in risk-taking was associated with an eighteen (ORadjusted = 1.18, 95% CI = 1.05–1.33) or six percent (ORadjusted = 1.06, 95% CI = 1.01, 1.12) increase in the likelihood of drinking hazardously, respectively. The findings related to the interaction between stress and inhibitory control were relatively complex. For example, thirty–year–olds that rated themselves as impatient and reported less stress tended to drink more (ORadjusted = 1.22, 95% CI = 1.00–1.48).
Conclusions Data from four nationally representative birth cohorts suggests that alcohol use during the pandemic increased in up to thirty percent of individuals. Hazardous drinking was observed in up to ten percent of respondents. Stress and inhibitory control were related to this but effects were age dependent. Governments should carefully consider the impact of personality and stress that may affect alcohol consumption in at-risk individuals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JMC is funded by an ESRC Doctoral Training Partnership grant. MOP receives funding from the Foundation for Liver Research. The funders had no role in study design, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The UCL Centre for Longitudinal Studies, who administered the survey, played no role in the analysis of the data, preparation of the manuscript, or decision to submit the manuscript for publication. All authors had full access to all data in the study. All authors were responsible for the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used in this work were from the UK Data Service. The registration for the access to the data from UK Data Service was done via University of Portsmouth. Access to the data was given by UK Data Service with the Project Number: 197137. As a secondary analysis was carried out, full ethical review was not required. Thus, the University of Portsmouth Ethics Screening Tool was used for assessment (reference number: ETHICS-10155).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos